Joaquim José Coutinho Ferreira
AuthID: R-000-7JF
151
TITLE: Change in OFF-/ON-Time After Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone in Patients who Ended the 1-Year BIPARK-I Extension Study on Opicapone 50mg Full Text
AUTHORS: Poewe, W; Ferreira, JJ; Lees, A; Rascol, O; Ikedo, F; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTHORS: Poewe, W; Ferreira, JJ; Lees, A; Rascol, O; Ikedo, F; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: 
WOS
WOS IN MY: 
ORCID
ORCID152
TITLE: Efficacy of Opicapone in Patients with Parkinson's Disease with Levodopa Dose Reduction: a Pooled Post-Hoc Analysis of BIPARK-I and II Full Text
AUTHORS: Rascol, O; Poewe, W; Ferreira, JJ; Lees, A; Santos, AT; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTHORS: Rascol, O; Poewe, W; Ferreira, JJ; Lees, A; Santos, AT; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID153
TITLE: Reader response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial
AUTHORS: Rato, ML; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: NEUROLOGY, VOLUME: 94, ISSUE: 14
AUTHORS: Rato, ML; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: NEUROLOGY, VOLUME: 94, ISSUE: 14
154
TITLE: Strategies to minimize placebo effects in research investigations
AUTHORS: Rodrigues, FB; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: PLACEBO EFFECTS IN NEUROLOGIC DISEASE, VOLUME: 153
AUTHORS: Rodrigues, FB; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: PLACEBO EFFECTS IN NEUROLOGIC DISEASE, VOLUME: 153
155
TITLE: Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease
AUTHORS: Martignon, C; Pedrinolla, A; Ruzzante, F; Giuriato, G; Laginestra, FG; Bouca Machado, R; Ferreira, JJ; Tinazzi, M; Schena, F; Venturelli, M;
PUBLISHED: 2020, SOURCE: AGING CLINICAL AND EXPERIMENTAL RESEARCH, VOLUME: 33, ISSUE: 2
AUTHORS: Martignon, C; Pedrinolla, A; Ruzzante, F; Giuriato, G; Laginestra, FG; Bouca Machado, R; Ferreira, JJ; Tinazzi, M; Schena, F; Venturelli, M;
PUBLISHED: 2020, SOURCE: AGING CLINICAL AND EXPERIMENTAL RESEARCH, VOLUME: 33, ISSUE: 2
156
TITLE: Impulse Control Behaviours in People with Parkinson's Disease: Findings from the Parkinson's Disease Real-World Impact Assessment (PRISM) Study Full Text
AUTHORS: Antonini, A; Tolosa, E; Ferreira, JJ; Lees, A; Foltynie, T; Ebersbach, G; Rascol, O; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTHORS: Antonini, A; Tolosa, E; Ferreira, JJ; Lees, A; Foltynie, T; Ebersbach, G; Rascol, O; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID157
TITLE: Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis Full Text
AUTHORS: Ferreira, JJ; Poewe, W; Antonini, A; Gama, H; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTHORS: Ferreira, JJ; Poewe, W; Antonini, A; Gama, H; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID158
TITLE: Changes in Activities of Daily Living and Motor Function in Patients Switching from Entacapone or Placebo to Opicapone who Ended BIPARK-I Extension on Opicapone 50mg Full Text
AUTHORS: Tolosa, E; Ferreira, JJ; Lees, A; Stocchi, F; Santos, AT; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTHORS: Tolosa, E; Ferreira, JJ; Lees, A; Stocchi, F; Santos, AT; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID159
TITLE: Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease
AUTHORS: Leitao, R; Guerreiro, C; Nunes, RG; Goncalves, N; Galati, G; Rosario, M; Guedes, LC; Ferreira, JJ; Reimao, S;
PUBLISHED: 2020, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 9, ISSUE: 2
AUTHORS: Leitao, R; Guerreiro, C; Nunes, RG; Goncalves, N; Galati, G; Rosario, M; Guedes, LC; Ferreira, JJ; Reimao, S;
PUBLISHED: 2020, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 9, ISSUE: 2
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID160
TITLE: Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology Full Text
AUTHORS: Oliveira, SR; Dionisio, PA; Guedes, LC; Goncalves, N; Coelho, M; Rosa, MM; Amaral, JD; Ferreira, JJ; Rodrigues, CMP;
PUBLISHED: 2020, SOURCE: BIOMOLECULES, VOLUME: 10, ISSUE: 6
AUTHORS: Oliveira, SR; Dionisio, PA; Guedes, LC; Goncalves, N; Coelho, M; Rosa, MM; Amaral, JD; Ferreira, JJ; Rodrigues, CMP;
PUBLISHED: 2020, SOURCE: BIOMOLECULES, VOLUME: 10, ISSUE: 6
